These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3061349)

  • 1. Therapeutic immunoadsorption of acetylcholine receptor antibodies in myasthenia gravis.
    Sato T; Ishigaki Y; Komiya T; Tsuda H
    Ann N Y Acad Sci; 1988; 540():554-6. PubMed ID: 3061349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myasthenia gravis].
    Tanaka K
    Nihon Rinsho; 2004 May; 62 Suppl 5():580-5. PubMed ID: 15197988
    [No Abstract]   [Full Text] [Related]  

  • 3. Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis.
    Berta E; Confalonieri P; Simoncini O; Bernardi G; Busnach G; Mantegazza R; Cornelio F; Antozzi C
    Int J Artif Organs; 1994 Nov; 17(11):603-8. PubMed ID: 7744521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 5. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains.
    Lazaridis K; Evaggelakou P; Bentenidi E; Sideri A; Grapsa E; Tzartos SJ
    J Neuroimmunol; 2015 Jan; 278():19-25. PubMed ID: 25595248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption therapy for myasthenia gravis.
    Shibuya N; Sato T; Osame M; Takegami T; Doi S; Kawanami S
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):578-81. PubMed ID: 8201327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy.
    Psaridi-Linardaki L; Trakas N; Mamalaki A; Tzartos SJ
    J Neuroimmunol; 2005 Feb; 159(1-2):183-91. PubMed ID: 15652418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies in Myasthenia Gravis].
    Higuchi O
    Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoadsorption--a new treatment of myasthenia gravis].
    Berning T; Krummenerl T; Glaser J; Paulus H; van Husen N
    Med Klin (Munich); 1988 Feb; 83(4):125-8. PubMed ID: 3285161
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up study of relapse in symptoms and reelevation of acetylcholine receptor antibody titers in patients with myasthenia gravis.
    Komiya T; Sato T
    Ann N Y Acad Sci; 1988; 540():605-7. PubMed ID: 3207287
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
    Pták J
    Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies.
    Lagoumintzis G; Zisimopoulou P; Trakas N; Grapsa E; Poulas K; Tzartos SJ
    J Neuroimmunol; 2014 Feb; 267(1-2):1-6. PubMed ID: 24412396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with intravenous immunoglobulin in myasthenia gravis.
    Arsura E
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S170-9. PubMed ID: 2791345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains.
    Zisimopoulou P; Lagoumintzis G; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Aug; 200(1-2):133-41. PubMed ID: 18603305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISA for detection of IgG & IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Khajuria A; Subbalaxmi B; Ahuja GK
    Indian J Med Res; 1986 Feb; 83():187-95. PubMed ID: 3710546
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency.
    Kostelidou K; Trakas N; Tzartos SJ
    J Neuroimmunol; 2007 Oct; 190(1-2):44-52. PubMed ID: 17764755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasmapheresis in patients with myasthenia gravis].
    Konishi T
    Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravis.
    Oger JJ
    Ann N Y Acad Sci; 1993 Jun; 681():110-2. PubMed ID: 8357159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.